Company News
Johnson & Johnson to buy V-Wave for up to $1.7bn
Johnson & Johnson said on Tuesday that it has agreed to buy V-Wave, a privately-held company focused on developing treatment options for patients with heart failure, for up to $1. 7bn.
Hobbycraft on brink of being bought by Modella Capital - report
Arts and crafts retailer Hobbycraft is reportedly on the brink of being sold to a specialist investor whose executives have backed chains including Paperchase and Tie Rack.
Sports entertainment driving strong trading for Light Science Technologies
Light Science Technologies, which operates across three divisions - controlled environment agriculture (CEA), contract electronics manufacturing (CEM), and passive fire protection (PFP) - announced strong trading in its CEM division on Tuesday, with the receipt of a third order from a key customer in the sports entertainment sector.
OptiBiotix reports solid first-half operational progress
Obesity-focussed life science company OptiBiotix Health updated the market on its commercial activities for the first half on Tuesday, reported significant advancements in expanding its presence in key markets, particularly in the United States and Asia, while also investing in direct-to-consumer e-commerce channels to drive growth and profitability.
Chariot announces start of drilling at Anchois project
Africa-focussed energy company Chariot announced the start of drilling operations at the Anchois gas project in the Lixus offshore licence, offshore Morocco, on Tuesday.
Beeks Financial Cloud secures further extension to JSE Colo 2.0 partnership
Cloud computing and connectivity provider Beeks Financial Cloud said on Tuesday that it had secured a further extension of its JSE Colo 2. 0 partnership with IPC into a second data centre location.
Renalytix terminates formal sale process
Renalytix, a company specialising in artificial intelligence-enabled diagnostics for kidney disease, announced the termination of its formal sale process on Tuesday.
Empresaria swings to first-half operating loss
Specialist staffing firm Empresaria swung to an operating loss in its first half, it reported on Tuesday, reflecting the continued impact of difficult market conditions on its financial performance.
N4 Pharma reports positive progress with SRI collaboration
N4 Pharma, a specialist pharmaceutical company focused on the development of Nuvec, a novel delivery system for cancer treatments, gene therapy, and vaccines, updated the market on its collaboration with SRI International on Tuesday.
H&T Group upbeat on first-half growth
Pawnbroker H&T Group reported a 12. 5% increase in first-half profit before tax on Tuesday, to £9. 9m, compared to £8. 8m in the first half of 2023.
BT Group slides as CityFibre strikes deal with Sky
BT Group slumped on Tuesday after competitor CityFibre announced a long-term broadband partnership with Sky.
Triple Point Social Housing transfers leases on 38 properties
Triple Point Social Housing REIT announced on Tuesday that it has successfully transferred the leases of 38 properties, previously leased to Parasol, to Westmoreland Housing Association.
Drax strikes £450m sustainability-linked RCF
Power generation business Drax said on Tuesday that it has struck a new sustainability-linked £450. 0m revolving credit facility.
Gran Tierra agrees £174m acquisition of i3 Energy
Gran Tierra Energy has agreed to acquire i3 Energy, it was announced on Tuesday morning, in a cash and share deal worth £174. 1m.
Trading suspension lifted as MobilityOne reports full-year losses
E-commerce infrastructure payment specialist MobilityOne announced its audited financial results for the year ended 31 December on Tuesday, allowing trading in its shares to resume.
Wood Group swings to H1 operating loss but FY guidance maintained
Wood Group said on Tuesday that it swung to an operating loss in the first half as revenue fell, but the engineering firm backed its outlook for this year and the next.
Diversified Energy acquires $69m package of East Texas gas assets
Diversified Energy announced a conditional agreement to acquire a package of natural gas assets in eastern Texas on Tuesday, for $69m.
GSK lung cancer drug gets FDA breakthrough designation
Pharmaceutical giant GSK announced on Tuesday that the US Food and Drug Administration (FDA) has granted breakthrough therapy designation to its investigational drug, GSK5764227 (GSK'227), for the treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) who had experienced disease progression following platinum-based chemotherapy.
Antofagasta's first-half profits fall as expected
Copper miner Antofagasta reported a 7% drop in half-year profits as higher prices were offset by falling volumes and higher depreciation and amortisation, though the bottom line came in slightly ahead of market forecasts.